Literature DB >> 24909356

MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.

J Huang1, S-Y Zhang, Y-M Gao, Y-F Liu, Y-B Liu, Z-G Zhao, K Yang.   

Abstract

MicroRNAs are a class of small, non-coding RNAs that can negatively regulate protein-coding genes, and are associated with almost all known physiological and pathological processes, especially cancer. The number of studies documenting miRNA expression patterns in malignancy continues to expand rapidly, with continuously gained critical information regarding how aberrantly expressed miRNAs may contribute to carcinogenesis. miRNAs can influence cancer pathogenesis, playing a potential role as either oncogenes or tumour suppressors. Recently, several miRNAs have been reported to exert different regulatory functions in oesophageal cancer - the carcinoma typically arising from the epithelial lining of the oesophagus. These miRNAs also have potential clinical applications towards developing biomarkers or targets for possible use in diagnosis or therapy in oesophageal cancer. In this review, we have summarized the two (oncogenic or tumour suppressive) roles of miRNAs here, and their applications as potential biomarkers or therapeutic targets, which may illuminate future treatment for oesophageal cancer.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24909356      PMCID: PMC6496620          DOI: 10.1111/cpr.12109

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  70 in total

1.  Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study.

Authors:  Ajay Bansal; I H Lee; X Hong; V Anand; S C Mathur; S Gaddam; A Rastogi; S B Wani; N Gupta; M Visvanathan; P Sharma; L K Christenson
Journal:  Am J Gastroenterol       Date:  2011-03-15       Impact factor: 10.864

2.  MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma.

Authors:  Yang Ni; Long Meng; Liguang Wang; Wei Dong; Hongchang Shen; Guanghui Wang; Qi Liu; Jiajun Du
Journal:  Gene       Date:  2012-12-28       Impact factor: 3.688

3.  MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.

Authors:  Jian Sun; Zhaoli Chen; Xiaogang Tan; Fang Zhou; Fengwei Tan; Yibo Gao; Nan Sun; Xiaohui Xu; Kang Shao; Jie He
Journal:  Med Oncol       Date:  2013-01-05       Impact factor: 3.064

4.  Prognostic significance of differentially expressed miRNAs in esophageal cancer.

Authors:  Yuxin Hu; Arlene M Correa; Ashraful Hoque; Baoxiang Guan; Fei Ye; Jie Huang; Stephen G Swisher; Tsung Teh Wu; Jaffer A Ajani; Xiao-Chun Xu
Journal:  Int J Cancer       Date:  2011-01-01       Impact factor: 7.396

5.  RNA polymerase III transcribes human microRNAs.

Authors:  Glen M Borchert; William Lanier; Beverly L Davidson
Journal:  Nat Struct Mol Biol       Date:  2006-11-12       Impact factor: 15.369

6.  A novel chemotherapeutic arene ruthenium(II) drug Rawq01 altered the effect of microRNA-21 on PTEN/AKT signaling pathway in esophageal cancer cells.

Authors:  Wenhao Weng; Qiong Wu; Yongchun Yu; Wenjie Mei; Xinghe Wang
Journal:  Anticancer Res       Date:  2013-12       Impact factor: 2.480

Review 7.  MicroRNA in the pathogenesis and prognosis of esophageal cancer.

Authors:  Jian Gu; Yan Wang; Xifeng Wu
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Trends in esophageal cancer incidence by histology, United States, 1998-2003.

Authors:  Katrina F Trivers; Susan A Sabatino; Sherri L Stewart
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

9.  miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2.

Authors:  Hai-Feng Zhang; Kai Zhang; Lian-Di Liao; Li-Yan Li; Ze-Peng Du; Bing-Li Wu; Jian-Yi Wu; Xiu-E Xu; Fa-Min Zeng; Bo Chen; Hui-Hui Cao; Meng-Xiao Zhu; Li-Hua Dai; Lin Long; Zhi-Yong Wu; Raymond Lai; Li-Yan Xu; En-Min Li
Journal:  Carcinogenesis       Date:  2013-09-24       Impact factor: 4.944

10.  Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy.

Authors:  Hong Yu; Bensong Duan; Lin Jiang; Mei Lin; Haihui Sheng; Junxing Huang; Hengjun Gao
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

View more
  49 in total

Review 1.  New insights into MicroRNAs involves in drug resistance in diffuse large B cell lymphoma.

Authors:  Xin Yu; Zheng Li
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

2.  MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.

Authors:  Cheng-Jun Sui; Feng Xu; Wei-Feng Shen; Bing-Hua Dai; Jiong-Jiong Lu; Min-Feng Zhang; Jia-Mei Yang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

Review 3.  Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer.

Authors:  Christine Kestens; Peter D Siersema; Jantine W P M van Baal
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.

Authors:  Yu Mao; Jia Liu; Dakai Zhang; Baosheng Li
Journal:  Tumour Biol       Date:  2016-01-13

5.  MicroRNA-765 regulates neural stem cell proliferation and differentiation by modulating Hes1 expression.

Authors:  Siou Li; Weina Zhao; Qing Xu; Yang Yu; Changhao Yin
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

6.  miR-143 suppresses the proliferation of NSCLC cells by inhibiting the epidermal growth factor receptor.

Authors:  Hong-Bo Zhang; Li-Chao Sun; Lan Ling; Lu-Hong Cong; Rui Lian
Journal:  Exp Ther Med       Date:  2016-07-27       Impact factor: 2.447

7.  miR-320 inhibited ovarian cancer oncogenicity via targeting TWIST1 expression.

Authors:  Chunyang Li; Ping Duan; Jianguang Wang; Xiaosheng Lu; Jing Cheng
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

8.  MicroRNA-26b regulates cancer proliferation migration and cell cycle transition by suppressing TRAF5 in esophageal squamous cell carcinoma.

Authors:  Zhuo Chen; Liang Zhao; Feng Zhao; Guanghai Yang; Jianjun Wang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

9.  miR-488 acts as a tumor suppressor gene in gastric cancer.

Authors:  Yan Zhao; Guifang Lu; Xiquan Ke; Xinlan Lu; Xin Wang; Hongxia Li; Mudan Ren; Shuixiang He
Journal:  Tumour Biol       Date:  2016-01-06

10.  microRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression.

Authors:  Yongping Li; Ruixue Huang; Ling Wang; Junsheng Hao; Qiong Zhang; Rui Ling; Jun Yun
Journal:  Cell Prolif       Date:  2015-11-02       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.